PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies

Pallavi V.Raja Manuri, Matthew H. Wilson, Sourindra N. Maiti, Tiejuan Mi, Harjeet Singh, Simon Olivares, Margaret J. Dawson, Helen Huls, Dean A. Lee, Pulivarthi H. Rao, Joseph Michael Kaminski, Yozo Nakazawa, Stephen Gottschalk, Partow Kebriaei, Elizabeth J. Shpall, Richard E. Champlin, Laurence J.N. Cooper

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Nonviral integrating vectors can be used for expression of therapeutic genes. piggyBac (PB), a transposon/transposase system, has been used to efficiently generate induced pluripotent stems cells from somatic cells, without genetic alteration. In this paper, we apply PB transposition to express a chimeric antigen receptor (CAR) in primary human T cells. We demonstrate that T cells electroporated to introduce the PB transposon and transposase stably express CD19-specific CAR and when cultured on CD19+ artificial antigen-presenting cells, numerically expand in a CAR-dependent manner, display a phenotype associated with both memory and effector T cell populations, and exhibit CD19-dependent killing of tumor targets. Integration of the PB transposon expressing CAR was not associated with genotoxicity, based on chromosome analysis. PB transposition for generating human T cells with redirected specificity to a desired target such as CD19 is a new genetic approach with therapeutic implications.

Original languageEnglish (US)
Pages (from-to)427-437
Number of pages11
JournalHuman Gene Therapy
Volume21
Issue number4
DOIs
StatePublished - Apr 1 2010

Fingerprint

Transposases
Antigen Receptors
T-Lymphocytes
Neoplasms
CD19 Antigens
Induced Pluripotent Stem Cells
Antigen-Presenting Cells
Chromosomes
Phenotype
Gene Expression
Therapeutics
Population

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Manuri, P. V. R., Wilson, M. H., Maiti, S. N., Mi, T., Singh, H., Olivares, S., ... Cooper, L. J. N. (2010). PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Human Gene Therapy, 21(4), 427-437. https://doi.org/10.1089/hum.2009.114

PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. / Manuri, Pallavi V.Raja; Wilson, Matthew H.; Maiti, Sourindra N.; Mi, Tiejuan; Singh, Harjeet; Olivares, Simon; Dawson, Margaret J.; Huls, Helen; Lee, Dean A.; Rao, Pulivarthi H.; Kaminski, Joseph Michael; Nakazawa, Yozo; Gottschalk, Stephen; Kebriaei, Partow; Shpall, Elizabeth J.; Champlin, Richard E.; Cooper, Laurence J.N.

In: Human Gene Therapy, Vol. 21, No. 4, 01.04.2010, p. 427-437.

Research output: Contribution to journalArticle

Manuri, PVR, Wilson, MH, Maiti, SN, Mi, T, Singh, H, Olivares, S, Dawson, MJ, Huls, H, Lee, DA, Rao, PH, Kaminski, JM, Nakazawa, Y, Gottschalk, S, Kebriaei, P, Shpall, EJ, Champlin, RE & Cooper, LJN 2010, 'PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies', Human Gene Therapy, vol. 21, no. 4, pp. 427-437. https://doi.org/10.1089/hum.2009.114
Manuri, Pallavi V.Raja ; Wilson, Matthew H. ; Maiti, Sourindra N. ; Mi, Tiejuan ; Singh, Harjeet ; Olivares, Simon ; Dawson, Margaret J. ; Huls, Helen ; Lee, Dean A. ; Rao, Pulivarthi H. ; Kaminski, Joseph Michael ; Nakazawa, Yozo ; Gottschalk, Stephen ; Kebriaei, Partow ; Shpall, Elizabeth J. ; Champlin, Richard E. ; Cooper, Laurence J.N. / PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. In: Human Gene Therapy. 2010 ; Vol. 21, No. 4. pp. 427-437.
@article{682fa73e0a3240c0a9be25b3f2f21ed8,
title = "PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies",
abstract = "Nonviral integrating vectors can be used for expression of therapeutic genes. piggyBac (PB), a transposon/transposase system, has been used to efficiently generate induced pluripotent stems cells from somatic cells, without genetic alteration. In this paper, we apply PB transposition to express a chimeric antigen receptor (CAR) in primary human T cells. We demonstrate that T cells electroporated to introduce the PB transposon and transposase stably express CD19-specific CAR and when cultured on CD19+ artificial antigen-presenting cells, numerically expand in a CAR-dependent manner, display a phenotype associated with both memory and effector T cell populations, and exhibit CD19-dependent killing of tumor targets. Integration of the PB transposon expressing CAR was not associated with genotoxicity, based on chromosome analysis. PB transposition for generating human T cells with redirected specificity to a desired target such as CD19 is a new genetic approach with therapeutic implications.",
author = "Manuri, {Pallavi V.Raja} and Wilson, {Matthew H.} and Maiti, {Sourindra N.} and Tiejuan Mi and Harjeet Singh and Simon Olivares and Dawson, {Margaret J.} and Helen Huls and Lee, {Dean A.} and Rao, {Pulivarthi H.} and Kaminski, {Joseph Michael} and Yozo Nakazawa and Stephen Gottschalk and Partow Kebriaei and Shpall, {Elizabeth J.} and Champlin, {Richard E.} and Cooper, {Laurence J.N.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1089/hum.2009.114",
language = "English (US)",
volume = "21",
pages = "427--437",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies

AU - Manuri, Pallavi V.Raja

AU - Wilson, Matthew H.

AU - Maiti, Sourindra N.

AU - Mi, Tiejuan

AU - Singh, Harjeet

AU - Olivares, Simon

AU - Dawson, Margaret J.

AU - Huls, Helen

AU - Lee, Dean A.

AU - Rao, Pulivarthi H.

AU - Kaminski, Joseph Michael

AU - Nakazawa, Yozo

AU - Gottschalk, Stephen

AU - Kebriaei, Partow

AU - Shpall, Elizabeth J.

AU - Champlin, Richard E.

AU - Cooper, Laurence J.N.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Nonviral integrating vectors can be used for expression of therapeutic genes. piggyBac (PB), a transposon/transposase system, has been used to efficiently generate induced pluripotent stems cells from somatic cells, without genetic alteration. In this paper, we apply PB transposition to express a chimeric antigen receptor (CAR) in primary human T cells. We demonstrate that T cells electroporated to introduce the PB transposon and transposase stably express CD19-specific CAR and when cultured on CD19+ artificial antigen-presenting cells, numerically expand in a CAR-dependent manner, display a phenotype associated with both memory and effector T cell populations, and exhibit CD19-dependent killing of tumor targets. Integration of the PB transposon expressing CAR was not associated with genotoxicity, based on chromosome analysis. PB transposition for generating human T cells with redirected specificity to a desired target such as CD19 is a new genetic approach with therapeutic implications.

AB - Nonviral integrating vectors can be used for expression of therapeutic genes. piggyBac (PB), a transposon/transposase system, has been used to efficiently generate induced pluripotent stems cells from somatic cells, without genetic alteration. In this paper, we apply PB transposition to express a chimeric antigen receptor (CAR) in primary human T cells. We demonstrate that T cells electroporated to introduce the PB transposon and transposase stably express CD19-specific CAR and when cultured on CD19+ artificial antigen-presenting cells, numerically expand in a CAR-dependent manner, display a phenotype associated with both memory and effector T cell populations, and exhibit CD19-dependent killing of tumor targets. Integration of the PB transposon expressing CAR was not associated with genotoxicity, based on chromosome analysis. PB transposition for generating human T cells with redirected specificity to a desired target such as CD19 is a new genetic approach with therapeutic implications.

UR - http://www.scopus.com/inward/record.url?scp=77950953208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950953208&partnerID=8YFLogxK

U2 - 10.1089/hum.2009.114

DO - 10.1089/hum.2009.114

M3 - Article

VL - 21

SP - 427

EP - 437

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 4

ER -